There is good news for parents with infants between 16.5 and 33 pounds with a history of life threatening anaphylaxis. Kaleo, the pharmaceutical company behind the life-saving medication, Auvi Q, announced that a 0.1 mg dose for their epinephrine autoinjector will be available starting May 1, 2018.
Contact allergy is a delayed reaction that can causes rashes. Reactions can range in severity from mild redness to blistering of the skin. There are two types of contact dermatitis: irritant and allergic.
A study published in this month’s JAMA Pediatrics suggest that there is an association between use of acid suppressive medications and antibiotics early in infancy and the development of allergy.
You May have Oral Allergy Syndrome.A common phenomenon that people with seasonal allergies may experience is itching of the mouth when eating raw fruits and vegetables.
Aimmune Therapeutics is a biopharmaceutical company that is investigating oral immunotherapy as a treatment for food allergy. Currently there is no F.D.A approved treatment for food allergy.
